Skip to content

Clinical study on the treatment of rhinitis sicca with sodium hyaluronate adjustable nasal irrigator

Clinical study on the treatment of rhinitis sicca with sodium hyaluronate adjustable nasal irrigator

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105164
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinitis sicca

Interventions

Control group:Physiological seawater adjustable nasal irrigator
Experimental group:Sodium hyaluronate adjustable nasal irrigator

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Symptoms: Dry nose sensation, little and thick nasal discharge, nosebleeds, itchy nasal cavity, and dryness in the nasopharynx. Physical signs: Nasal endoscopy often reveals dry and congested nasal mucosa, which appears grayish-white or dark red, losing its normal luster. There are often dry, thick secretions, scabs or blood scabs on it. The surface of the nasal mucosa is eroded and ulcers occur. The mucosal lesions are most obvious in the anterior part of the nasal cavity. A diagnosis can be made if one or more of the above symptoms and signs are present.

Exclusion criteria

Exclusion criteria: (1)Those with dry rhinitis and chronic inflammation of the lower respiratory tract; (2) Those confirmed by examination to be caused by certain latent lesions in the mouth, nose, throat, esophagus, neck or the whole body; (3) Those who have used drugs for treating dry rhinitis or other medications within the past 30 days; (4) Pregnant or lactating women; (5) Those who are allergic to this medicine; (6) Those with severe cardiovascular, liver, kidney and hematopoietic system diseases, etc. (7) Mentally ill patients.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS);Nasal endoscopy examination score;

Countries

China

Contacts

Public ContactDongdong Zhu

China-Japan Union Hospital of Jilin University

zhudd@jlu.edu.cn+86 135 7877 2290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026